>Mercado de POCT de lípidos en Oriente Medio y África, por tipo (instrumentos, consumibles y kits), aplicación (hiperlipidemia, hipertrigliceridemia, hiperlipoproteinemia, hipercolesterolemia familiar, enfermedad de Tangier, otros), modo (pruebas con receta, pruebas sin receta), marca (Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek, otros), plataforma (ensayos de flujo lateral (pruebas de inmunocromatografía), diagnóstico molecular, inmunoensayos, tiras reactivas, microfluídica), usuario final (hospitales, centros de diagnóstico profesional, atención domiciliaria, laboratorios de investigación, otros usuarios finales), canal de distribución (licitación directa, ventas minoristas), país (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos, Egipto, Israel y resto de Oriente Medio y África) Tendencias de la industria y pronóstico hasta 2028
Análisis y perspectivas del mercado: mercado de POCT de lípidos en Oriente Medio y África
Se espera que el mercado de POCT de lípidos gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 3,0% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 10,05 millones para 2028. El aumento en el número de infecciones crónicas ha llevado a las personas a optar por kits y productos de punto de atención para las pruebas y, por lo tanto, esto impulsará el crecimiento del mercado de POCT de lípidos.
La POCT se caracteriza por ser una prueba que se puede realizar cerca del paciente, donde se puede tomar una decisión médica de inmediato, incluidos los resultados y el seguimiento . La POCT de lípidos también se denomina prueba de lípidos con el paciente y permite a los médicos medir con precisión los resultados de diagnóstico en tiempo real y con calidad de laboratorio en menos de minutos en lugar de horas.
Los nuevos avances biotecnológicos han creado inmensos factores de impulso e impulsan el crecimiento del mercado de POCT de lípidos. El alto costo de los productos puede obstaculizar el crecimiento de este mercado. Se espera que el aumento del gasto en atención médica actúe como una oportunidad para el crecimiento de este mercado. La falta de alineación con los resultados de las pruebas obtenidas de los laboratorios está creando un inmenso desafío para este mercado.
El informe de mercado de lípidos POCT proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado de lípidos POCT, comuníquese con Data Bridge Market Research para obtener un resumen de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de POCT de lípidos
The lipid POCT market is segmented into seven notable segments which are based on the type, application, mode, brand, platform, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
- On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
- On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
- On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
- On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
- On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
- On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.
Middle East and Africa Lipid POCT Market Country Level Analysis
Middle East and Africa lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.
The countries covered in the Middle East and Africa lipid POCT market report are the South Africa, Saudi Arabia, UAE, Egypt, Israel and rest of Middle East and Africa.
South Africa is going to dominate in the Middle East and Africa lipid POCT market because of the increasing diagnosis rate and awareness about the cardiovascular disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufacturers is Creating New Opportunities for Players in the Lipid POCT Market
The lipid POCT market also provides you with detailed market analysis for every country growth in aesthetic industry with lipid POCT market sales, impact of advancement in the lipid POCT market and changes in regulatory scenarios with their support for the lipid POCT market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Lipid POCT Market Share Analysis
The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East and Africa lipid POCT market.
The major companies covered in the Middle East and Africa lipid POCT market report are Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., PTS Diagnostics, Trinity Biotech, Siemens Healthcare GmbH (a subsidiary of Siemens), Samsung Medison Co., Ltd., Nova Biomedical, ACON Laboratories, Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the lipid POCT market.
For instance,
- En noviembre de 2020, SD Biosensor, INC. anunció su asociación con DKSH Korea para desarrollar un negocio de medición de azúcar en sangre en farmacias. Esto ayudará a la empresa a diversificar su mercado en los próximos años.
La colaboración, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de POCT de lípidos, lo que también proporciona el beneficio para que la organización mejore su oferta para el mercado de POCT de lípidos.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA LIPID POCT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DISTRIBUTION CHANNEL LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 IMPROVING DIAGNOSIS SEEKING RATE
5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS
5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE
5.1.5 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 PRODUCT RECALLS
5.2.2 HIGH COSTS OF PRODUCTS
5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING HEALTHCARE EXPENDITURE
5.3.3 PANDEMIC OUTBREAK OF COVID-19
5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 LACK OF ACCESSIBILITY
6 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA LIPID POCT MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19
6.5 CONCLUSION:
1 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY TYPE
1.1 OVERVIEW
1.2 INSTRUMENTS
1.2.1 ANALYZERS
1.2.1.1 PORTABLE
1.2.1.2 HANDHELD
1.2.1.3 STANDALONE
1.2.2 METER
1.2.3 BLOOD MONITORING DEVICE
1.2.4 OTHER POC PRODUCTS
1.3 CONSUMABLES AND KITS
1.3.1 CHOLESTEROL TEST KITS
1.3.2 STRIPS
1.3.3 ACCESSORIES
1.3.4 OTHERS
2 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY APPLICATION
2.1 OVERVIEW
2.2 HYPERLIPIDEMIA
2.3 HYPERTRIGLYCERIDEMIA
2.4 HYPERLIPOPROTEINEMIA
2.5 FAMILIAL HYPERCHOLESTEROLEMIA
2.6 TANGIER DISEASE
2.7 OTHERS
3 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY MODE
3.1 OVERVIEW
3.2 PRESCRIPTION-BASED TESTING
3.3 OTC-BASED TESTING
4 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY BRAND
4.1 OVERVIEW
4.2 ROCHE REFLOTRON
4.3 ROCHE COBAS B 101
4.4 ALERE CHOLESTECH LDX
4.5 ALERE AFINION
4.6 PTS CARDIOCHEK
4.7 OTHERS
5 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY PLATFORM
5.1 OVERVIEW
5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS
5.3 MOLECULAR DIAGNOSTICS
5.4 IMMUNOASSAYS
5.5 DIPSTICKS
5.6 MICROFLUIDICS
6 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY END USER
6.1 OVERVIEW
6.2 HOSPITALS
6.3 PROFESSIONAL DIAGNOSTIC CENTERS
6.3.1 CLINICAL LABORATORIES
6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS
6.4 HOME CARE
6.5 RESEARCH LABORATORIES
6.6 OTHER END USERS
7 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 DIRECT TENDERS
7.3 RETAIL SALES
8 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY REGION
8.1 MIDDLE EAST & AFRICA
8.1.1 SOUTH AFRICA
8.1.2 SAUDI ARABIA
8.1.3 U.A.E.
8.1.4 EGYPT
8.1.5 ISRAEL
8.1.6 REST OF MIDDLE EAST & AFRICA
9 MIDDLE EAST AND AFRICA LIPID POCT MARKET: COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
10 SWOT ANALYSIS
11 COMPANY PROFILES
11.1 F. HOFFMANN-LA ROCHE LTD
11.1.1 COMPANY SNAPSHOT
11.1.2 REVENUE ANALYSIS
11.1.3 COMPANY SHARE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENT
11.2 ABBOTT
11.2.1 COMPANY SNAPSHOT
11.2.2 REVENUE ANALYSIS
11.2.3 COMPANY SHARE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENT
11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)
11.3.1 COMPANY SNAPSHOT
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 QUEST DIAGNOSTICS INCORPORATED
11.4.1 COMPANY SNAPSHOT
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPMENTS
11.5 A. MENARINI DIAGNOSTICS S.R.L
11.5.1 COMPANY SNAPSHOT
11.5.2 COMPANY SHARE ANALYSIS
11.5.3 PRODUCT PORTFOLIO
11.5.4 RECENT DEVELOPMENT
11.6 ACON LABORATORIES, INC.
11.6.1 COMPANY SNAPSHOT
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENT
11.7 AMD SOLUTIONS
11.7.1 COMPANY SNAPSHOT
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 CALLEGARI SRL
11.8.1 COMPANY SNAPSHOT
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 EUROMEDIX
11.9.1 COMPANY SNAPSHOT
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENT
11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.
11.10.1 COMPANY SNAPSHOT
11.10.2 PRODUCT PORTFOLIO
11.10.3 RECENT DEVELOPMENTS
11.11 JANT PHARMACAL CORPORATION
11.11.1 COMPANY SNAPSHOT
11.11.2 PRODUCT PORTFOLIO
11.11.3 RECENT DEVELOPMENT
11.12 MICO BIOMED
11.12.1 COMPANY SNAPSHOT
11.12.2 PRODUCT PORTFOLIO
11.12.3 RECENT DEVELOPMENTS
11.13 NOVA BIOMEDICAL
11.13.1 COMPANY SNAPSHOT
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 PRIMA LAB SA
11.14.1 COMPANY SNAPSHOT
11.14.2 PRODUCT PORTFOLIO
11.14.3 RECENT DEVELOPMENTS
11.15 PTS DIAGNOSTICS
11.15.1 COMPANY SNAPSHOT
11.15.2 PRODUCT PORTFOLIO
11.15.3 RECENT DEVELOPMENTS
11.16 SD BIOSENSOR, INC.
11.16.1 COMPANY SNAPSHOT
11.16.2 PRODUCT PORTFOLIO
11.16.3 RECENT DEVELOPMENTS
11.17 SKYLA CORPORATION
11.17.1 COMPANY SNAPSHOT
11.17.2 PRODUCT PORTFOLIO
11.17.3 RECENT DEVELOPMENTS
11.18 TASCOM
11.18.1 COMPANY SNAPSHOT
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENT
11.19 TRINITY BIOTECH
11.19.1 COMPANY SNAPSHOT
11.19.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.2 SAMSUNG MEDISON CO., LTD.
11.20.1 COMPANY SNAPSHOT
11.20.2 PRODUCT PORTFOLIO
11.20.3 RECENT DEVELOPMENT
12 QUESTIONNAIRE
13 RELATED REPORTS
Lista de Tablas
LIST OF TABLES
TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:
TABLE 1 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 50 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 SOUTH AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 SOUTH AFRICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 SOUTH AFRICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 SOUTH AFRICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 58 SOUTH AFRICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 SOUTH AFRICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 SOUTH AFRICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 61 SOUTH AFRICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 62 SOUTH AFRICA LIPID POCT MARKET, BY BRAND,2019-2028 (UNITS)
TABLE 63 SOUTH AFRICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 64 SOUTH AFRICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 SOUTH AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 SOUTH AFRICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 67 SAUDI ARABIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 SAUDI ARABIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 SAUDI ARABIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 70 SAUDI ARABIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 71 SAUDI ARABIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 SAUDI ARABIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 SAUDI ARABIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 74 SAUDI ARABIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 75 SAUDI ARABIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 76 SAUDI ARABIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 77 SAUDI ARABIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 SAUDI ARABIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 SAUDI ARABIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 U.A.E. LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 U.A.E. INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 U.A.E. ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 83 U.A.E. ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 84 U.A.E. CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 U.A.E. LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 U.A.E. LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 87 U.A.E. LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 88 U.A.E. LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 89 U.A.E. LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 90 U.A.E. LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 91 U.A.E. PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 U.A.E. LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 93 EGYPT LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 EGYPT INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 95 EGYPT ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 96 EGYPT ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 97 EGYPT CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 98 EGYPT LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 EGYPT LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 100 EGYPT LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 101 EGYPT LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 102 EGYPT LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 103 EGYPT LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 104 EGYPT PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 EGYPT LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 106 ISRAEL LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 ISRAEL INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 ISRAEL ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 109 ISRAEL ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 110 ISRAEL CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 111 ISRAEL LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 ISRAEL LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 113 ISRAEL LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 114 ISRAEL LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 115 ISRAEL LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 116 ISRAEL LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 117 ISRAEL PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 118 ISRAEL LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 REST OF MIDDLE EAST & AFRICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
Lista de figuras
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA LIPID POCT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA LIPID POCT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA LIPID POCT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA LIPID POCT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA LIPID POCT MARKET: MULTIVARIATE MODELLING
FIGURE 8 MIDDLE EAST AND AFRICA LIPID POCT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA LIPID POCT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA LIPID POCT MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LIPID POCT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA LIPID POCT MARKET
FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT
FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016
FIGURE 1 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, 2020
FIGURE 2 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 3 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 4 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 5 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, 2020
FIGURE 6 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 8 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 9 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, 2020
FIGURE 10 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, CAGR (2021-2028)
FIGURE 12 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY MODE, LIFELINE CURVE
FIGURE 13 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, 2020
FIGURE 14 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)
FIGURE 16 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY BRAND, LIFELINE CURVE
FIGURE 17 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, 2020
FIGURE 18 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)
FIGURE 20 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, 2020
FIGURE 22 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 24 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY END USER, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 26 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 28 MIDDLE EAST AND AFRICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 29 MIDDLE EAST & AFRICA LIPID POCT MARKET: SNAPSHOT (2020)
FIGURE 30 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY COUNTRY (2020)
FIGURE 31 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 32 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 33 MIDDLE EAST & AFRICA LIPID POCT MARKET: BY TYPE (2021-2028)
FIGURE 34 MIDDLE EAST AND AFRICA LIPID POCT MARKET: COMPANY SHARE 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
